Skip to content
Clinical Trials – home
Research site

Appletreeclinics Network Sp. z o.o.

Poland Ul. Ks. Bp. Wincentego Tymienieckiego 20, 90-349 Lodz, Poland

  • 1 trial recruiting
  • Dermatitis atopic · Colitis ulcerative · Smoking cessation therapy
  • Adults and children

About Specializations

Appletreeclinics Network Sp. z o.o. in Lodz, Poland specialises in clinical trials of conditions such as Dermatitis atopic, Colitis ulcerative, Smoking cessation therapy, Ex-tobacco user, and other specialisations. This site conducts important research.

Main research areas of the site

Dermatology and Immune-Mediated Skin Diseases

At Appletreeclinics Ośrodek Badań Klinicznych in Lodz, research in skin and connective tissue diseases and immune system diseases is focused on conditions such as atopic dermatitis and moderate to severe plaque psoriasis. These studies are designed to assess new treatment options and better understand how to improve symptom control and long-term disease management.

  • Evaluating new therapies for moderate to severe atopic dermatitis
  • Studying treatment effects in moderate to severe plaque psoriasis
  • Assessing the safety of longer-term care for chronic inflammatory skin disease

This area of research brings together efforts to improve both effectiveness and safety for people living with persistent inflammatory skin conditions.

Gastroenterology and Inflammatory Bowel Disease

Clinical trials at this site also cover digestive system diseases, with a strong focus on moderate to severe ulcerative colitis. The research is centered on evaluating long-term treatment safety and supporting better disease control for patients with chronic intestinal inflammation.

  • Investigating treatment safety in ulcerative colitis
  • Monitoring long-term outcomes in gastrointestinal inflammation
  • Supporting improved management of chronic bowel disease

These studies help expand knowledge about therapies aimed at reducing disease burden and maintaining stable control over time.

Neurology and Migraine Prevention

Research in nervous system diseases includes trials for migraine, with an emphasis on finding better ways to prevent attacks and improve daily functioning for adults affected by recurrent headaches. The work is aimed at testing whether emerging preventive approaches can offer meaningful relief where previous treatments have not been enough.

  • Exploring new options for migraine prevention
  • Focusing on patients with ongoing headache burden
  • Evaluating whether preventive treatment can improve quality of life

This line of research reflects the site’s interest in neurological conditions that can significantly affect everyday activity and well-being.

Behavioral Health and Nicotine Cessation

The site also participates in psychiatry and psychology research related to behavior and behavior mechanisms, including studies on stopping electronic cigarette and tobacco use. These trials aim to evaluate whether adding behavioral support to medication can improve quit rates for people motivated to stop vaping or smoking.

  • Supporting cessation of electronic cigarette use
  • Addressing dual use of vaping and tobacco products
  • Testing approaches that combine medication and behavioral support

This research focuses on practical strategies to help people break nicotine dependence and maintain abstinence over time.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Ks. Bp. Wincentego Tymienieckiego 2090-349 LodzPoland
Recruiting now
1 trial
Conditions studied
6

More sites in LodzPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

11 clinical trials

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cytisine
  • Sponsor:University of Rzeszow

Colitis ulcerative

Not yet recruiting
Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Colitis ulcerative

Not yet recruiting
Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax
Countries:PolandPoland
  • Participants:0–17 years
  • Sponsor:Amgen Inc.

Psoriasis

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Vibozilimod
  • Sponsor:Sun Pharmaceutical Industries Limited
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Abrocitinib
  • Sponsor:Pfizer Inc.

Dermatitis atopic

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Vibozilimod
  • Sponsor:Sun Pharmaceutical Industries Limited

Dermatitis atopic

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Dermatitis atopic

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.